Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes

Background: Uncertainty remains as to whether females benefit as much as males from percutaneous coronary intervention (PCI) in the setting of an acute coronary syndrome (ACS). Methods: We compared 802 women with 2151 men presenting with ACS, undergoing PCI from April 2004 to October 2006 from the M...

Full description

Bibliographic Details
Main Authors: Al-Fiadh, A., Andrianopoulos, N., Farouque, O., Yan, B., Duffy, S., Charter, K., Tongyoo, S., New, G., Yip, T., Brennan, A., Proimos, G., Reid, Christopher, Ajani, A., Clark, D.
Format: Journal Article
Published: 2011
Online Access:http://hdl.handle.net/20.500.11937/4922
_version_ 1848744651099471872
author Al-Fiadh, A.
Andrianopoulos, N.
Farouque, O.
Yan, B.
Duffy, S.
Charter, K.
Tongyoo, S.
New, G.
Yip, T.
Brennan, A.
Proimos, G.
Reid, Christopher
Ajani, A.
Clark, D.
author_facet Al-Fiadh, A.
Andrianopoulos, N.
Farouque, O.
Yan, B.
Duffy, S.
Charter, K.
Tongyoo, S.
New, G.
Yip, T.
Brennan, A.
Proimos, G.
Reid, Christopher
Ajani, A.
Clark, D.
author_sort Al-Fiadh, A.
building Curtin Institutional Repository
collection Online Access
description Background: Uncertainty remains as to whether females benefit as much as males from percutaneous coronary intervention (PCI) in the setting of an acute coronary syndrome (ACS). Methods: We compared 802 women with 2151 men presenting with ACS, undergoing PCI from April 2004 to October 2006 from the Melbourne Interventional Group registry. Clinical characteristics, in-hospital, 30-day and 1-year outcomes were compared. Results: Women were older (69.6 ± 11.6 vs. 62.17 ± 12.3 years, p < 0.001), and had more diabetes (27.1% vs. 19.6%, p < 0.001) and hypertension (70.3% vs. 53.9%, p < 0.001) than men. Women were less likely to present with ST-elevation myocardial infarction (30.5% vs. 37.9%, p < 0.001). Bleeding (3.6% vs. 0.8%, p < 0.001) was higher among women. Thirty-day mortality (4.7 vs. 2.4%, p < 0.001) and MACE (10.1 vs. 6.4%, p < 0.001) were higher in women. Gender was an independent predictor of overall MACE at 30 days (OR 1.45, 95% CI 1.04–2.02, p = 0.03) but not death. At 12 months, there were no significant differences in mortality (6.4% vs. 4.8%, p = 0.09), myocardial infarction (5.5% vs. 5.0%, p = 0.64), target vessel revascularization (7.9% vs. 7.0%, p = 0.42) and MACE (16.3% vs. 14%, p = 0.13) between women and men. Conclusions: There is an early hazard amongst women undergoing PCI for ACS, but not at 12 months. These data suggest that gender should not affect the decision to offer PCI but further gender specific studies are warranted.
first_indexed 2025-11-14T06:04:51Z
format Journal Article
id curtin-20.500.11937-4922
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T06:04:51Z
publishDate 2011
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-49222017-09-13T14:44:02Z Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes Al-Fiadh, A. Andrianopoulos, N. Farouque, O. Yan, B. Duffy, S. Charter, K. Tongyoo, S. New, G. Yip, T. Brennan, A. Proimos, G. Reid, Christopher Ajani, A. Clark, D. Background: Uncertainty remains as to whether females benefit as much as males from percutaneous coronary intervention (PCI) in the setting of an acute coronary syndrome (ACS). Methods: We compared 802 women with 2151 men presenting with ACS, undergoing PCI from April 2004 to October 2006 from the Melbourne Interventional Group registry. Clinical characteristics, in-hospital, 30-day and 1-year outcomes were compared. Results: Women were older (69.6 ± 11.6 vs. 62.17 ± 12.3 years, p < 0.001), and had more diabetes (27.1% vs. 19.6%, p < 0.001) and hypertension (70.3% vs. 53.9%, p < 0.001) than men. Women were less likely to present with ST-elevation myocardial infarction (30.5% vs. 37.9%, p < 0.001). Bleeding (3.6% vs. 0.8%, p < 0.001) was higher among women. Thirty-day mortality (4.7 vs. 2.4%, p < 0.001) and MACE (10.1 vs. 6.4%, p < 0.001) were higher in women. Gender was an independent predictor of overall MACE at 30 days (OR 1.45, 95% CI 1.04–2.02, p = 0.03) but not death. At 12 months, there were no significant differences in mortality (6.4% vs. 4.8%, p = 0.09), myocardial infarction (5.5% vs. 5.0%, p = 0.64), target vessel revascularization (7.9% vs. 7.0%, p = 0.42) and MACE (16.3% vs. 14%, p = 0.13) between women and men. Conclusions: There is an early hazard amongst women undergoing PCI for ACS, but not at 12 months. These data suggest that gender should not affect the decision to offer PCI but further gender specific studies are warranted. 2011 Journal Article http://hdl.handle.net/20.500.11937/4922 10.1016/j.ijcard.2010.05.018 restricted
spellingShingle Al-Fiadh, A.
Andrianopoulos, N.
Farouque, O.
Yan, B.
Duffy, S.
Charter, K.
Tongyoo, S.
New, G.
Yip, T.
Brennan, A.
Proimos, G.
Reid, Christopher
Ajani, A.
Clark, D.
Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes
title Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes
title_full Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes
title_fullStr Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes
title_full_unstemmed Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes
title_short Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes
title_sort contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes
url http://hdl.handle.net/20.500.11937/4922